Basic Information
FULPHILA™ SOLUTION FOR INJECTION IN PREFILLED SYRINGE 6MG/0.6ML
INJECTION, SOLUTION
Regulatory Information
SIN16012P
September 21, 2020
Prescription Only
Therapeutic
SUBCUTANEOUS
August 10, 2023
June 4, 2025
XL03AA13
Company Information
Active Ingredients
Pegfilgrastim
Strength: 6 mg / 0.6 ml
Detailed Information
Contraindications
**Contraindications** Hypersensitivity to the active substance or to any of the excipients.
Indication Information
**THERAPEUTIC INDICATIONS** Reduction in the duration of neutropenia and the incidence of febrile neutropenia in adult patients treated with cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes).